New onset of Graves' disease after controlled ovarian stimulation: A case report and brief literature review
International Journal of Gynecology & Obstetrics · 2025-03 · 168 (3) · 913-918
DOI: 10.1002/ijgo.15951 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 12.10.2024. Verfasst von Alberto Vassallo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Endocrine and Metabolic Sciences, Vita-Salute San Raffaele University, Milan, Italy. Hauptthemen laut MEDLINE: Graves Disease, Ovulation Induction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
De novo onset of Graves' disease (GD) after controlled ovarian stimulation (OS) is exceptional. Only one case of progression to GD after OS in a patient with pre‐existing subclinical hyperthyroidism has been reported. We describe the case of a patient with neither previous thyroid disorders nor autoimmunity who developed GD after OS for primary infertility. A 40‐year‐old woman with primary infertility underwent four cycles of OS. Her thyroid function performed before the last cycle was unremarkable (thyroid stimulating hormone [TSH] 1.9 mU/L, fT4 1.3 ng/dL, fT3 2.4 pg/mL), and thyroid autoimmunity was negative (anti‐thyroperoxidase antibodies and anti‐thyroglobuline antibodies). Six weeks after the last cycle she developed overt thyrotoxicosis (TSH < 0.005 mU/L, fT4 4.79 ng/dL, fT3 15.6 pg/mL) with anti‐thyrotropin receptor antibodies (TRAb) positivity (9.2 IU/L). She was diagnosed with GD and anti‐thyroid therapy was instituted. After 1 year of treatment, thyroid function was still suboptimal (TSH 0.2 mU/L, fT4 1.04 ng/dL, fT3 2.2 pg/mL), and TRAb titer still elevated (8.75 IU/L). Despite her desire to achieve pregnancy, a further cycle of OS was postponed until complete remission of thyroid dysfunction and withdrawal of anti‐thyroid therapy. Although TSH assay after OS is not recommended in euthyroid women without autoimmunity, in the presence of hyperthyroid symptoms throughout OS it is advisable to evaluate thyroid function and TRAb. It is advisable to carefully evaluate the course of GD before proceeding with further courses of OS that could lead to its exacerbation or recurrence. In cases where a strong desire for pregnancy persists, thyroidectomy may be proposed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Endocrine and Metabolic Sciences, Vita-Salute San Raffaele University, Milan, Italy.
- Endocrinology Unit, IRCCS Ospedale San Raffaele, Milan, Italy.
- Infertility Unit, Department Obstetrics and Gynecology, ASST Mantova, Mantua, Italy.
- Medical Department, ASST Mantova, Mantua, Italy.
- Endocrinology Unit, Medical Department, ASST Mantova, Mantua, Italy.
ORCID-Profile: Barbara Presciuttini
Zitieren
APA
Vassallo, A., Di Filippo, L., Frara, S., Bertoli, M., Pagani, M., & Presciuttini, B. (2025). New onset of Graves' disease after controlled ovarian stimulation: A case report and brief literature review. International Journal of Gynecology & Obstetrics, 168(3), 913-918. https://doi.org/10.1002/ijgo.15951
Vancouver
Vassallo A, Di Filippo L, Frara S, Bertoli M, Pagani M, Presciuttini B. New onset of Graves' disease after controlled ovarian stimulation: A case report and brief literature review. International Journal of Gynecology & Obstetrics. 2025;168(3):913-918. doi:10.1002/ijgo.15951
BibTeX
@article{Vassallo2025,
author = {Vassallo, Alberto and Di Filippo, Luigi and Frara, Stefano and Bertoli, Massimo and Pagani, Mauro and Presciuttini, Barbara},
title = {New onset of Graves' disease after controlled ovarian stimulation: A case report and brief literature review},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
volume = {168},
number = {3},
pages = {913--918},
doi = {10.1002/ijgo.15951}
}
EUVIMED